Nathan Lawrentschuk
Scientist
Andrew Scott Lab Ludwig Center at Melbourne
Ludwig Institute for Cancer Research
Australia
Biography
My principal responsibilities as a urological surgeon and urologic oncologist involve the management of patients with urologic malignancies. My translational research interests involve: • Hypoxia and angiogenesis in renal cell carcinoma. • Applications of optical imaging for diagnosis, surgical planning and outcomes of urologic malignancies, particularly prostate cancer. • Clinical trials evaluating small-molecule inhibitors in urologic malignancies. I am also interested in clinical research with a focus on outcomes research. I supervise multiple higher-degree students through the University of Melbourne. I am BJUI Associate Editor of the USANZ Supplement, which is published biannually.
Research Interest
Urology, oncology, cancer therepeutics, cancer diagnosis
Publications
-
Lawrentschuk, Nathan, et al. "‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging." BJU international 105.9 (2010): 1231-1236.
-
Valerio, Massimo, et al. "The role of focal therapy in the management of localised prostate cancer: a systematic review." European urology 66.4 (2014): 732-751.
-
Cher, Lawrence M., et al. "Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies." Journal of Nuclear Medicine 47.3 (2006): 410-418.
